Greenbrook TMS (NASDAQ:GBNH) Upgraded to Hold at Zacks Investment Research

Greenbrook TMS (NASDAQ:GBNH – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Monday, Zacks.com reports. According to Zacks, “Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other […]

Related Keywords

Montreal ,Quebec ,Canada ,United States ,Toronto ,Ontario ,Stifel Nicolaus ,Royce Associates ,Masters Capital Management ,Virtu Financial ,Zacks Investment Research ,Advisorshares Investments ,Canaccord Genuity Group ,Get Rating ,Transcranial Magnetic Stimulation ,Major Depressive Disorder ,Capital Management ,Shares Investments ,Montreal Can ,Greenbrook Tms ,Nasdaq Gbnh ,Gbnh ,Medical ,Upgrade ,